Lista de obras -

A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer

artículo científico publicado en 2015

A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer

artículo científico publicado en 2007

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

artículo científico publicado en 2014

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

artículo científico publicado en 2017

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

artículo científico publicado en 2014

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

artículo científico publicado en 2019

Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib

artículo científico publicado en 2009

Clinical development of mTor inhibitors for renal cancer

artículo científico publicado en 2017

Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.

artículo científico publicado en 2017

Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials

artículo científico publicado en 2017

Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.

artículo científico publicado en 2010

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

artículo científico publicado en 2013

Emerging combination therapies to overcome resistance in EGFR-driven tumors

artículo científico

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis

artículo científico publicado en 2017

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

artículo científico publicado en 2015

Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.

artículo científico publicado en 2006

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

artículo científico publicado en 2014

Jumping higher: is it still possible? The ALTTO trial challenge

artículo científico publicado en 2008

Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia.

artículo científico publicado en 2014

Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity

artículo científico publicado en 2016

Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis

scientific article published on 27 November 2018

New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

artículo científico publicado en 2016

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

artículo científico

Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer

artículo científico publicado en 2017

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report

artículo científico publicado en 2007

Pituitary gland metastasis from rectal cancer: report of a case and literature review

artículo científico publicado en 2013

Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies

artículo científico publicado en 2017

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

artículo científico publicado en 2016

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

artículo científico publicado en 2014

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

artículo científico publicado en 2017

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer

artículo científico publicado en 2016

Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review

artículo científico publicado en 2017

Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.

artículo científico publicado en 2017

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II tr

artículo científico publicado en 2010

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

artículo científico publicado en 2015

Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer

artículo científico publicado en 2015

Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers

artículo científico publicado en 2017

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.

artículo científico publicado en 2017

Targeted therapies in gastric cancer treatment: where we are and where we are going.

artículo científico publicado en 2016

The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis

artículo científico

Lista de obras de

A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer

A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib

Clinical development of mTor inhibitors for renal cancer

Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.

Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials

Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

Emerging combination therapies to overcome resistance in EGFR-driven tumors

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

Jumping higher: is it still possible? The ALTTO trial challenge

Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia.

Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity

Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis

New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report

Pituitary gland metastasis from rectal cancer: report of a case and literature review

Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer

Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review

Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II tr

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer

Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.

Targeted therapies in gastric cancer treatment: where we are and where we are going.

The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis